Cbdmd, INC 8-K filings

cbdMD has amended its Charlotte facility lease to reduce its footprint by 50% and extend the term through November 2031.

cbdMD, Inc. announced updated compensation for its independent directors, including restricted stock units and annual cash retainers.

cbdMD, Inc. shareholders approved a new equity compensation plan, a potential reverse stock split, and several dilutive share issuances at its 2026 Annual Meeting.

cbdMD, Inc. has acquired substantially all assets of Gaia Botanicals, LLC, including the Bluebird Botanicals brand, for common stock and an earnout, expanding its CBD product offerings.

cbdMD, Inc. announced it has regained full compliance with NYSE American continued listing standards, removing the '.BC' indicator.

cbdMD, Inc. announced a new three-year employment agreement for CEO and CFO T. Ronan Kennedy, alongside the approval of a 2025 Equity Compensation Plan reserving 891,316 shares.

cbdMD, Inc. announced preliminary unaudited financial results for the fourth quarter and fiscal year ended September 30, 2025, showing expected flat year-over-year net sales for the fiscal year and a 3-5% increase for the fourth quarter.

cbdMD, Inc. has raised $1.7 million through the issuance of Series B Convertible Preferred Stock to institutional investors, bolstering its working capital.

cbdMD, Inc. granted restricted stock units to independent and non-management employee directors and approved annual fees for independent directors on May 16, 2025.

cbdMD, Inc. completed an automatic conversion of preferred stock into common stock and a one-for-eight reverse stock split, effective May 6, 2025.

cbdMD, Inc. announces shareholder approval for the automatic conversion of Series A Preferred Stock into common stock, expected to eliminate $6.7 million in accrued dividend payments and $4 million in annual dividend obligations.

cbdMD, Inc. announces the full conversion of its Senior Secured Convertible Notes into common stock, eliminating debt and enhancing financial flexibility.

cbdMD, Inc. has significantly reduced its debt by converting Senior Secured Convertible Notes, issuing shares of common stock in the process.

cbdMD, Inc. has received a notice from the NYSE American for non-compliance with continued listing standards due to insufficient stockholders' equity.

cbdMD has appointed its CEO, T. Ronan Kennedy, to its Board of Directors, expanding the board to five members effective December 18, 2024.

cbdMD, Inc. has extended its warehouse lease for 19 months, ensuring operational continuity and providing time to evaluate long-term facility needs.

cbdMD, Inc. filed an amended report to correct a previously reported stockholders deficit to a stockholders equity of $3.1 million and announced an extension to its NYSE American listing compliance plan until December 5, 2025.

cbdMD, Inc. has acquired the 'CBD MD' trademark, settled litigation, and amended its debt agreement with institutional investors.

cbdMD has been granted an extension until December 5, 2025, by the NYSE American to regain compliance with listing standards after reporting a stockholders deficit.

cbdMD, Inc. has amended its previous 8-K filing to correct an accounting error related to a lease termination, resulting in a total gain of approximately $780,000.

cbdMD has finalized a settlement regarding its former executive office lease, resulting in a significant anticipated gain.

cbdMD, Inc. reports a total of 3,763,433 common shares outstanding and a remaining $1,076,963 principal balance on its convertible promissory notes as of July 19, 2024.

cbdMD, Inc. has submitted a plan to the NYSE American to regain compliance with continued listing standards after receiving a non-compliance notice.

cbdMD, Inc. has received a notice from the NYSE American for not meeting continued listing standards due to insufficient stockholders' equity.

cbdMD announced the appointment of a new Chief Accounting Officer, the election of directors, and the approval of several key proposals at its 2024 annual meeting of shareholders.

cbdMD, Inc. has entered into a license and forbearance agreement with HSKL, Inc., to address lease defaults and relocate its executive offices.

cbdMD, Inc. announces the commencement of non-deal roadshows using a newly furnished investor presentation.

cbdMD, Inc. has entered into a securities purchase agreement with institutional investors, securing $1.25 million in gross proceeds through the issuance of convertible promissory notes.